Randall E. Woods
Net Worth

Last updated:

What is Randall E. Woods net worth?

The estimated net worth of Mr. Randall E. Woods is at least $6,447,361 as of 19 Sep 2018. He owns shares worth $1 as insider and has received compensation worth at least $6,447,360 in Sophiris Bio, Inc..

What is the salary of Randall E. Woods?

Mr. Randall E. Woods salary is $537,280 per year as Pres, Chief Executive Officer & Director in Sophiris Bio, Inc..

How old is Randall E. Woods?

Mr. Randall E. Woods is 73 years old, born in 1952.

What stocks does Randall E. Woods currently own?

As insider, Mr. Randall E. Woods owns shares in one company:

Company Title Shares Price per share Total value
Sophiris Bio, Inc. (SPHS) Pres, Chief Executive Officer & Director 10,000 $0 $1

What does Sophiris Bio, Inc. do?

Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company's primary product candidate is PRX302 (topsalysin), which is in Phase III clinical trial for treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. It has a strategic relationship with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of PRX302 for the treatment of the symptoms of BPH, prostate cancer, prostatitis, or other diseases of the prostate; and license agreement with UVIC Industry Partnerships Inc. and The Johns Hopkins University with respect to the use of PRX302 for the development of therapeutics for the symptoms of BPH, prostate cancer, and other non-cancer diseases and conditions of the prostate. The company was formerly known as Protox Therapeutics Inc. and changed its name to Sophiris Bio, Inc. in April 2012. Sophiris Bio, Inc. was founded in 2002 and is based in La Jolla, California.

Randall E. Woods insider trading

Sophiris Bio, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 3,000 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 2,500 N/A N/A
Purchase
Common Stock 10,000 N/A N/A

Sophiris Bio key executives

Sophiris Bio, Inc. executives and other stock owners filed with the SEC: